Advertisement

Impact of Antimicrobial Resistance on Therapy of Bacterial Pneumonia in Children

  • B. Keith English
  • Steven C. Buckingham
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 582)

Keywords

Staphylococcus Aureus Streptococcus Pneumoniae Empiric Therapy Bacterial Pneumonia Pneumococcal Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abbasi, S., Orlicek, S.L., Almohsen, I., Luedtke, G., and English, B.K. (1996). Septic arthritis and osteomyelitis caused by penicillin and cephalosporin-resistant Streptococcus pneumoniae in a children’s hospital. Pediatr. Infect. Dis. J. 15, 78–83.PubMedCrossRefGoogle Scholar
  2. Adam, D. (2002) Global antibiotic resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50,Suppl: 1–5.PubMedGoogle Scholar
  3. Adem, P.V., Montgomery, C.P., Husain, A.N., Koogler, T.K., Arangelovich, V., Humilier, M., Boyle-Vavra, S., and Daum, R.S. (2005). Brief Report: Staphylococcus aureus Sepsis and the Waterhouse-Friderichsen Syndrome in Children. N. Engl. J. Med. 353, 1245–51.PubMedCrossRefGoogle Scholar
  4. Alfaro, C., Fergie, J., and Purcell, K. (2005). Emergence of community-acquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions. Pediatr. Infect. Dis. J. 24, 274–6.PubMedCrossRefGoogle Scholar
  5. American Academy of Pediatrics, Committee on Infectious Diseases (1997). Therapy for children with invasive pneumococcal infections. Pediatrics 99, 289–99.CrossRefGoogle Scholar
  6. Applebaum, P.C. (2002) Resistance among Streptococcus pneumoniae: implications for drug selection. Clin. Infect. Dis. 34, 1613–20.CrossRefGoogle Scholar
  7. Aspa, J., Rajas, O., Rodriguez de Castro, F., Blanquer, J., Zalacain R., Fenoll, A., de Celis, R., Vargas, A., Rodriguez Salvanes, F., Espana, P.P., Rello, J., and Torres, A. (2004). Pneumococcal Pneumonia in Spain Study Group. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin. Infect. Dis. 38, 787–98.PubMedCrossRefGoogle Scholar
  8. Austrian, R., and Gold, J. (1964) Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med 60, 759–70.PubMedGoogle Scholar
  9. Barrett, F.F., McGehee, R.F., Jr., and Finland, M. (1968). Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N. Engl. J. Med. 279, 441–8.PubMedCrossRefGoogle Scholar
  10. Black, S.B., Shinefield, H.R., Ling, S., Hansen, J., Fireman, B., Spring, D., Noyes, J., Lewis, E., Ray, P., Lee, J., and Hackell, J. (2002). Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr. Infect. Dis. J. 21, 810–5.PubMedCrossRefGoogle Scholar
  11. Bradley, J.S., and Connor, J.D. (1991). Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr. Infect. Dis. J. 10, 871–3.PubMedGoogle Scholar
  12. Bradley, J.S. (2002). Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines. Pediatr. Infect. Dis. J. 21, 592–8.PubMedCrossRefGoogle Scholar
  13. Braun, L., Craft, D., Williams, R., Tuamokumo, F., and Ottolini, M. (2005). Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr. Infect. Dis. J. 24, 622–6.PubMedCrossRefGoogle Scholar
  14. Buckingham, S.C., Brown, S.P., and Joaquin, V.H. (1998). Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J. Pediatr. 132, 174–6.PubMedCrossRefGoogle Scholar
  15. Buckingham, S.C., King, M.D., and Miller, M.L. (2003). Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr. Infect. Dis. J. 22, 499–504.PubMedCrossRefGoogle Scholar
  16. Buckingham, S.C., McDougal, L.K., Cathey, L.D., Comeaux, K., Craig, A.S., Fridkin, S.K., and Tenover, F.C. (2004). Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital. Pediatr. Infect. Dis. J. 23, 619–24.PubMedGoogle Scholar
  17. Byington, C.L., Spencer, L.Y., Johnson, T.A., Pavia, A.T., Allen, D., Mason, E.O., Kaplan, S., Carroll, K.C., Daly, J.A., Christenson, J.C., and Samore, M.H. (2002). An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin. Infect. Dis. 34, 434–40.PubMedCrossRefGoogle Scholar
  18. Chartrand, S.A., and McCracken, G.H., Jr. (1982). Staphylococcal pneumonia in infants and children. Pediatr. Infect. Dis. J. 1, 19–23.Google Scholar
  19. Chavez-Bueno, S., Bozdogan, B., Katz, K., Bowlware, K.L., Cushion, N., Cavuoti, D., Ahmad, N., McCracken, G.H., Jr., and Appelbaum, P.C. (2005). Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob. Agents Chemother. 49, 2283–8.PubMedCrossRefGoogle Scholar
  20. Chickering, H.T., and Park, J.H. (1919) Staphylococcus aureus pneumonia. JAMA 72, 617–26.Google Scholar
  21. Cunha, B.A. (2002). Clinical relevance of penicillin-resistant Streptococcus pneumoniae Semin. Respir. Infect. 17, 204–14.CrossRefGoogle Scholar
  22. Deeks, S.L., Palacio, R., Ruvinsky, R., Kertesz, D.A., Hortal, M., Rossi, A., Spika, J.S., and Di Fabio, J.L. (1999). Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics. 103, 409–13.PubMedCrossRefGoogle Scholar
  23. Dowell, S.F., Smith, T., Leversedge, K., and Snitzer, J. (1999). Failure of treatment of pneumonia associated with highly resistant pneumococci in a child. Clin. Infect. Dis. 29, 462–3.PubMedCrossRefGoogle Scholar
  24. Feikin, D.R., Schuchat, A., Kolczak, M., Barrett, N.L., Harrison, L.H., Lefkowitz, L., McGeer, A., Farley, M.M., Vugia, D.J., Lexau, C., Stefonek, K.R., Patterson, J.E., and Jorgensen, J.H. (2000). Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am. J. Public Health. 90, 223–9.PubMedCrossRefGoogle Scholar
  25. File, T.M., Jr. (2002). Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the signifi cance of beta-lactam resistant Streptococcus pneumoniae. Clin. Infect. Dis. 34, S17–26.CrossRefGoogle Scholar
  26. File, T.M., Jr. (2004). Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am. J. Med. 117,Suppl 3A: 39S–50S.PubMedGoogle Scholar
  27. Francis, J.S., Doherty, M.C., Lopatin, U., Johnston, C.P., Sinha, G., Ross, T., Cai, M., Hansel, N.N., Perl, T., Ticehurst, J.R., Carroll, K., Thomas, D.L., Nuermberger, E., and Bartlett, J.G. (2005). Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40, 100–7.PubMedCrossRefGoogle Scholar
  28. Frank, A.L., Marcinak, J.F., Mangat, P.D., Tjhio, J.T., Kelkar, S., Schreckenberger, P.C., and Quinn, J.P. (2002). Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21, 530–4.PubMedCrossRefGoogle Scholar
  29. Gonzalez, B.E., Martinez-Aguilar, G., Hulten, K.G., Hammerman, W.A., Coss-Bu, J., Avalos-Mishaan, A., Mason, E.O., Jr., and Kaplan, S.L. (2005). Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 115, 642–8.PubMedCrossRefGoogle Scholar
  30. Gonzalez, B.E., Hulten, K.G., Dishop, M.K., Lamberth, L.B., Hammerman, W.A., Mason, E.O., Jr., and Kaplan, S.L. (2005). Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis. 41, 583–90.PubMedCrossRefGoogle Scholar
  31. Gorak, E.J., Yamada, S.M., and Brown, J.D. (1999). Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin. Infect. Dis. 29, 797–800.PubMedGoogle Scholar
  32. Guillemot, D., Varon, E., Bernede, C., Weber, P., Henriet, L., Simon, S., Laurent, C., Lecoeur, H., and Carbon, C. (2005). Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin. Infect. Dis. 41, 930–8.PubMedCrossRefGoogle Scholar
  33. Hardie, W., Bokulic, R., Garcia, V.F., Reising, S.F., and Christie, C.D. (1996). Pneumococcal pleural empyemas in children. Clin. Infect. Dis. 22, 1057–63.PubMedGoogle Scholar
  34. Herold, B.C., Immergluck, L.C., Maranan, M.C., Lauderdale, D.S., Gaskin, R.E., Boyle-Vavra, S., Leitch, C.D., and Daum, R.S. (1998). Community-acquired methicillin-resistant Staphylococcus aureus in children with no identifi ed predisposing risk. JAMA 279, 593–8.PubMedCrossRefGoogle Scholar
  35. Hunt, C., Dionne, M., Delorme, M., et al. (1999). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997–1999. MMWR 48, 707–10.Google Scholar
  36. Kaplan, S.L., Afghani, B., Lopez, P., Wu, E., Fleishaker, D., Edge-Padbury, B., Naberhuis-Stehouwer, S., and Bruss, J.B. (2003). Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 22(Suppl), S178–85.PubMedGoogle Scholar
  37. Kaplan, S.L., Hulten, K.G., Gonzalez, B.E., Hammerman, W.A., Lamberth, L., Versalovic, J., and Mason, E.O., Jr. (2005). Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis. 40, 1785–91.PubMedCrossRefGoogle Scholar
  38. Karchmer, A.W. (1991). Staphylococcus aureus and vancomycin: the sequel. Ann. Intern. Med. 115, 739–41.PubMedGoogle Scholar
  39. Klugman, K.P. (2002). The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50(Suppl) S2, 1–5.PubMedCrossRefGoogle Scholar
  40. Kollef, M.H., Rello, J., Cammarata, S.K., Croos-Dabrera, R.V., and Wunderink, R.G. (2004). Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med. 30, 388–94.PubMedCrossRefGoogle Scholar
  41. Levine, D.P., Fromm, B.S., and Reddy, B.R. (1991). Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115, 674–80.PubMedGoogle Scholar
  42. Lowy, F.D. (1998). Medical Progress: Staphylococcus aureus Infections. N. Engl. J. Med. 339, 520–32.PubMedCrossRefGoogle Scholar
  43. Martinez-Aguilar, G., Hammerman, W.A., Mason, E.O., Jr., and Kaplan, S.L. (2003). Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 22, 593–8.PubMedCrossRefGoogle Scholar
  44. Martinez-Aguilar, G., Avalos-Mishaan. A., Hulten, K., Hammerman, W., Mason, E.O. Jr., and Kaplan, S.L. (2004). Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr. Infect. Dis. J. 23, 701–6.PubMedGoogle Scholar
  45. Martin, M.A. (1994). Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis. 14, 170–91.PubMedGoogle Scholar
  46. McCracken, G.H., Jr. (1995). Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr. Infect. Dis. J. 14, 424–8.PubMedCrossRefGoogle Scholar
  47. McIntosh, K. (2002). Community-acquired pneumonia in children. N. Engl. J. Med. 346, 429–37.PubMedCrossRefGoogle Scholar
  48. Michelow, I.C., Olsen, K., Lozano, J., Rollins, N.K., Duffy, L.B., Ziegler, T., Kauppila, J., Leinonen, M., and McCracken, G.H., Jr. (2004). Epidemiology and clinical characteristics of communityacquired pneumonia in hospitalized children. Pediatrics 113, 701–7.PubMedCrossRefGoogle Scholar
  49. Miller, L.G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer. A.S., Tang, A.W., Phung, T.O., and Spellberg, B. (2005). Necrotizing fasciitis caused by community-associated methicillinresistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352, 1445–53.PubMedCrossRefGoogle Scholar
  50. Pallares, R., Linares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P.F., Martin, R., and Gudiol, F. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333, 474–80.PubMedCrossRefGoogle Scholar
  51. Rebhan, A.W., and Edwards, H.E. (1960). Staphylococcal pneumonia: a review of 329 cases. Can. Med. Assoc. J. 82, 513–7.PubMedGoogle Scholar
  52. Sakoulas, G., Moise-Broder, P.A., Schentag, J., Forrest, A., Moellering, R.C., Jr., and Eliopoulos, G.M. (2004). Relationship of MIC and bactericidal activity to effi cacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol 42, 2398–402.PubMedCrossRefGoogle Scholar
  53. Schrag, S.J., McGee, L., Whitney, C.G., Beall, B., Craig, A.S., Choate, M.E., Jorgensen, J.H., Facklam, R.R., and Klugman, K.P.; Active Bacterial Core Surveillance Team (2004). Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob. Agents Chemother. 48, 3016–2.PubMedCrossRefGoogle Scholar
  54. Sloas, M.M., Barrett, F.F., Chesney, P.J., English, B.K., Hill, B.C., Tenover, F.C., and Leggiadro, R.J. (1992). Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 11, 662–6.PubMedGoogle Scholar
  55. Stevens, D.L., Herr, D., Lampiris, H., Hunt. J.L., Batts, D.H., and Hafkin, B. (2002). Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 34, 1481–90.PubMedCrossRefGoogle Scholar
  56. Tan, T.Q., Mason, E.O., Jr., Wald, E.R., Barson, W.J., Schutze, G.E., Bradley, J.S., Givner, L.B., Yogev, R., Kim, K.S., and Kaplan, S.L. (2002). Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 110, 1–6.PubMedCrossRefGoogle Scholar
  57. Tsolia, M.N., Psarras, S., Bossios, A., Audi, H., Paldanius, M., Gourgiotis, D., Kallergi. K., Kafetzis, D.A., Constantopoulos. A., and Papadopoulos, N.G. (2004). Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin. Infect. Dis. 39, 681–6PubMedCrossRefGoogle Scholar
  58. Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., and Knirsch, C. Linezolid CSSTI Study Group. (2005). Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 49, 2260–6.PubMedCrossRefGoogle Scholar
  59. Weisblum, B. (1995). Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39, 797–80.PubMedGoogle Scholar
  60. Whitney, C.G., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., Lynfield, R., Reingold. A., Cieslak, P.R., Pilishvili, T., Jackson, D., Facklam, R.R., Jorgensen, J.H., and Schuchat, A (2003). Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737–46.PubMedCrossRefGoogle Scholar
  61. Whitney, C.G., and Klugman, K.P. (2004), Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Semin. Pediatr. Infect. Dis. 15, 86–93.PubMedCrossRefGoogle Scholar
  62. Wunderink, R.G., Rello, J., Cammarata, S.K., Croos-Dabrera, R.V., and Kollef, M.H. (2003). Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124, 1789–97.PubMedCrossRefGoogle Scholar
  63. Yu, V.L., Chiou, C.C., Feldman, C., Ortqvist, A., Rello, J., Morris, A.J., Baddour, L.M., Luna, C.M., Snydman, D.R., Ip, M., Ko, W.C., Chedid, M.B., Andremont, A., and Klugman, K.P. (2003). International Pneumococcal Study Group. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin. Infect. Dis. 37, 230–7.PubMedCrossRefGoogle Scholar
  64. Yu, V.L., and Baddour, L.M. (2004). Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality. Clin. Infect. Dis. 39, 1086–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • B. Keith English
    • 1
  • Steven C. Buckingham
  1. 1.The University of Tennessee Health Science CenterMemphisUSA

Personalised recommendations